Session Details

S014 Practical Management of Birthmarks and Hamartomas

Fri, Mar 8, 1:00 PM - 4:00 PM
Room 30B
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

The evaluation and management of birthmarks and their associated syndromes is a tantamount skill for any dermatologist caring for children. In this session, we will offer a practical, step by step approach that you can implement in your clinical practice. The discussion will incorporate the most up-to-date advances in our understanding of infantile hemangiomas, vascular anomalies, congenital melanocytic nevi and epidermal nevi.

LEARNING OBJECTIVES

1.

Identify features of infantile hemangiomas which are associated with need for systemic evaluation

2.

Identify features of vascular stains and melanocytic birthmarks which may have extra-cutaneous associations

3.

Recognize cutaneous findings which may be associated with underlying developmental anomalies and next steps in evaluation

SCHEDULE

9:00 PM

Introduction

Vikash Sudhir Oza, MD, FAAD

9:05 PM

The hemangioma checklist

Sonal D. Shah, MD, FAAD

9:35 PM

The flat vascular birthmark checklist

Ilona J. Frieden, MD, FAAD

10:05 PM

The congenital melanocytic birthmark checklist

Elena B. Hawryluk, MD, PhD, FAAD

10:35 PM

The cutaneous hamartoma checklist

Vikash Sudhir Oza, MD, FAAD

11:05 PM

The developmental defect checklist

Beth Ann Drolet, MD, FAAD

SPEAKERS

Beth Ann Drolet, MD, FAAD

Beth Ann Drolet, MD, FAAD

Ilona J. Frieden, MD, FAAD

Ilona J. Frieden, MD, FAAD

Elena B. Hawryluk, MD, PhD, FAAD

Elena B. Hawryluk, MD, PhD, FAAD

Vikash Sudhir Oza, MD, FAAD

Vikash Sudhir Oza, MD, FAAD

Sonal D. Shah, MD, FAAD

Sonal D. Shah, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Beth Ann Drolet, MD, FAAD

Arkayli Biosciences – Founder(Stock); Novartis Pharmaceuticals Corp. – Investigator(No Compensation Received); Peds Derm Research LLC – Founder(Stock); Pierre Fabre Dermatologie – Other(Grants/Research Funding); Venthera – Consultant(Fees);

Ilona J. Frieden, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);

Elena B. Hawryluk, MD, PhD, FAAD

Apogee Therapeutics – Advisory Board(Honoraria); DermTech Inc. – Investigator(No Compensation Received); Gritstone Oncology – Employee(Salary); PathAI – Advisory Board(Stock Options); Predictive Oncology, Inc – Board of Directors(Other Financial Benefit); Skin Analytics – Consultant(Fees); UpToDate, Inc – Other(Other Financial Benefit);

Vikash Sudhir Oza, MD, FAAD

Apogee BioPharm – Consultant(Honoraria); ASLAN Pharmaceuticals – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Dove/Unilever – Consultant(Fees); La Roche Posay Dermatologique – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); VisualDx – Other(Fees);

Sonal D. Shah, MD, FAAD

UpToDate, Inc – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);